Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Department Of Translational Genomics |
RCV000171212 | SCV000221409 | likely pathogenic | not provided | criteria provided, single submitter | research | ||
ARUP Laboratories, |
RCV000171212 | SCV001477765 | likely pathogenic | not provided | 2019-10-07 | criteria provided, single submitter | clinical testing | The COL2A1 c.3230G>T; p.Gly1077Val variant (rs786205477), to our knowledge, is not described in the medical literature but is reported in ClinVar (Variation ID: 191036). This variant is absent from general population databases (Exome Variant Server and Genome Aggregation Database), indicating it is not a common polymorphism. The glycine at codon 1077 is highly conserved, and computational analyses (SIFT, PolyPhen-2) predict that this variant is deleterious. This variant disrupts the repeating Gly-X-Y sequence motif of the collagen triple helix and is predicted to impair collagen function (Barat-Houari 2016). Based on available information, this variant is considered to be likely pathogenic. References: Barat-Houari M et al. Mutation Update for COL2A1 Gene Variants Associated with Type II Collagenopathies. Hum Mutat. 2016 Jan;37(1):7-15. |